Pilocarpine by Allergan and AbbVie is the first drug for age-related farsightedness.
Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.
Deucravacitinib by Bristol-Myers Squibb can help with psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, lupus nephritis, and systemic lupus erythematosus.
The pharmaceutical industry continues to fight hard against the devastating neurodegenerative disease.
Oral ozanimod will provide clinical remission of ulcerative colitis for a third of patients.